Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Future Med Chem. 2009 Oct;1(7):1333–1349. doi: 10.4155/fmc.09.93

Table 2.

Effect of cannabinoids on cytokine and chemokine production.

Cannabinod Receptor Cell/tissue/serum Effect Ref.
THC ND Macrophage cell line (RAW264.7) Decreases TNF-α [40]
THC ND Peritoneal macrophages Increases IL-1α and IL-1β [41]
THC ND Human cell lines Decreases TNF-α, GM-CSF and IFN-γ, IL-10
Increases IL-8
[26]
THC CB1 and CB2 independent Rat microglial cells Decreases TNF-α, IL-1α, IL-1β and IL-6 [28]
In vivo WIN55,212-2 and HU-210 CB1 dependent Serum Decreases TNF-α, IL-12
Increases IL-10
[29]
Ajulemic acid ND Human synovial monocyte-derived macrophage Decreases IL-6 and IL-1β [32]
HU-308 CB2 dependent Serum and liver homogenates Decreases TNF-α, MIP-1α and MIP-2 [33]
CP55,940 WIN55,212–2 CB1 and CB2 independent Rheumatoid fibroblast-like synoviocytes IL-6 and IL-8 [34]
2-AG CB2 dependent Promyelocytic leukemia cell line (HL-60) Increases IL-8, CXCL8 and CCL2 [37]

AG: Arachidonoylglycerol; CB: Cannabinoid receptor; CCL: CC-chemokine ligand; CXCL8: CXC-chemokine ligand 8; ND: Not determined; THC: Tetrahydrocannabinol.